Stent placement in esophageal cancer as a bridge to surgery

Vleggaar, Frank P.

doi:10.1016/j.gie.2009.03.025

Cited by 12 publications

(6 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among these, PGA sheet, a biodegradable suture material, could be used to prevent post-ESD esophageal stricture because of its advantages of reinforcing suture and minimal scar contracture, although the limitation of instability between the PGA sheet and wound surface after long-term pasting still exists[ 9 - 11 ]. Another popular method is stent placement, which is frequently used with covered self-expandable metal material, and has been verified to have curative effects on refractory stricture to some extent, although its complications, such as translocation and promotion of granulation tissue proliferation, still affect its clinical outcomes in EC patients[ 12 , 13 ].…”

Section: Introductionmentioning

confidence: 99%

Effect of polyglycolic acid sheet plus esophageal stent placement in preventing esophageal stricture after endoscopic submucosal dissection in patients with early-stage esophageal cancer: A randomized, controlled trial

Chai¹,

Feng²,

Li³

et al. 2018

WJG

View full text Add to dashboard Cite

AIMTo assess the effect of polyglycolic acid (PGA) plus stent placement compared with stent placement alone in the prevention of post-endoscopic submucosal dissection (ESD) esophageal stricture in early-stage esophageal cancer (EC) patients.METHODSSeventy EC patients undergoing ESD were enrolled in this randomized, controlled study. Patients were allocated randomly at a 1:1 ratio into two groups as follows: (1) PGA plus stent group (PGA sheet-coated stent placement was performed); and (2) Stent group (only stent placement was performed). This study was registered on http://www.chictr.org.cn (No. chictr-inr-16008709).RESULTSThe occurrence rate of esophageal stricture in the PGA plus stent group was 20.5% (n = 7), which was lower than that in the stent group (46.9%, n = 15) (P = 0.024). The mean value of esophageal stricture time was 59.6 ± 16.1 d and 70.7 ± 28.6 d in the PGA plus stent group and stent group (P = 0.174), respectively. Times of balloon dilatation in the PGA plus stent group were less than those in the stent group [4 (2-5) vs 6 (1-14), P = 0.007]. The length (P = 0.080) and diameter (P = 0.061) of esophageal strictures were numerically decreased in the PGA plus stent group, whereas no difference in location (P = 0.232) between the two groups was found. Multivariate logistic analysis suggested that PGA plus stent placement (P = 0.026) was an independent predictive factor for a lower risk of esophageal stricture, while location in the middle third (P = 0.034) and circumferential range = 1/1 (P = 0.028) could independently predict a higher risk of esophageal stricture in EC patients after ESD.CONCLUSIONPGA plus stent placement is more effective in preventing post-ESD esophageal stricture compared with stent placement alone in EC patients with early-stage disease.

show abstract

Section: Introductionmentioning

confidence: 99%

Effect of polyglycolic acid sheet plus esophageal stent placement in preventing esophageal stricture after endoscopic submucosal dissection in patients with early-stage esophageal cancer: A randomized, controlled trial

Chai¹,

Feng²,

Li³

et al. 2018

WJG

View full text Add to dashboard Cite

show abstract

“…6 The indications for SEMS use have expanded to include relief from dysphagia in patients with resectable EC and for those who require neoadjuvant treatment before resection. [7][8][9][10][11][12][13][14][15][16] Self-expanding covered metallic stent insertion can immediately relieve dysphagia and allow for the maintenance of oral nutrition, 17 and a series of articles highlight that their use is associated with safe early results. [7][8][9][10][11][12][13][14][15][16] However, the impact of SEMS insertion on oncologic outcomes in the neoadjuvant setting is unknown.…”

mentioning

confidence: 99%

Self-Expanding Covered Metallic Stent as a Bridge to Surgery in Esophageal Cancer: Impact on Oncologic Outcomes

Mariette¹,

Gronnier²,

Duhamel³

et al. 2015

Journal of the American College of Surgeons

View full text Add to dashboard Cite

“…Despite its usefulness in palliating symptoms, the use of bridge SEMS placement has a negative impact on oncological outcomes according to recent studies. [27][28][29] Mariette et al 28 reported that patients who underwent SEMS placement as bridging therapy had earlier recurrence (7 vs. 9 months) and a lower 3-year overall survival rate (25 vs. 44%). Increased incidence of SEMSrelated complications, mechanical injury caused by SEMS, Fig.…”

Section: Stent Placement In Various Situations Stent Placement As a Bmentioning

confidence: 99%

Stenting for Advanced Esophageal Carcinoma

2018

View full text Add to dashboard Cite

Esophageal cancer is the eighth most common malignancy and the sixth leading cause of cancer-related deaths worldwide. Most patients with esophageal cancer are identified at an advanced stage of disease. Less than 20% of patients are candidates for curable surgical resection. Self-expandable metallic stents (SEMSs) have recently been used for the palliation of incurable esophageal cancer. Since their use was first reported in the late 1970s, stents have evolved rapidly from rigid plastic tubes to flexible SEMSs. This review covers various aspects of SEMS placement for advanced esophageal cancer and discusses multiple types of SEMSs, considerations in stent placement, complications, and recently developed radiation-emitting stents.

show abstract

Stent placement in esophageal cancer as a bridge to surgery

Cited by 12 publications

References 12 publications

Effect of polyglycolic acid sheet plus esophageal stent placement in preventing esophageal stricture after endoscopic submucosal dissection in patients with early-stage esophageal cancer: A randomized, controlled trial

Effect of polyglycolic acid sheet plus esophageal stent placement in preventing esophageal stricture after endoscopic submucosal dissection in patients with early-stage esophageal cancer: A randomized, controlled trial

Self-Expanding Covered Metallic Stent as a Bridge to Surgery in Esophageal Cancer: Impact on Oncologic Outcomes

Stenting for Advanced Esophageal Carcinoma

Contact Info

Product

Resources

About